FDA Fast-Tracks Respiratory Syncytial Virus (RSV) mRNA ‘Vaccine’: Are We Creating a Public Health Disaster’

Dr Joseph Mercola

Respiratory syncytial virus (RSV) — a respiratory virus that causes typically mild cold-like symptoms — is emerging out of season around the world

Most children have been exposed to RSV by their second birthday and recover without incident. In rare cases, RSV can progress to pneumonia or bronchiolitis (inflammation of the small airways of the lungs)

August 3, 2021, the U.S. Food and Drug Administration granted fast-track designation to Moderna for an mRNA-based injection against RSV

As with coronavirus, previous efforts to develop an RSV vaccine have met with failure as test subjects have a tendency to die or become seriously ill when exposed to the wild virus, thanks to paradoxical immune enhancement (PIE), also known as antibody dependent enhancement (ADE)

Moderna’s RSV shot uses the same lipid nanoparticle as its COVID-19 injection. The mRNA will encode for a prefusion F glycoprotein, a protein that mediates the RSV virus’ entry into your cells and is known to elicit a neutralizing antibody response

[…]

RSV Emerges Out of Season Around the World

According to reports, RSV is now raging around the world, from New Zealand1 to Japan2 and the U.S.,3 where it hit so hard in June 2021 that the Centers for Disease Control and Prevention issued an emergency alert4 for parts of the southern United States.

The CDC encouraged testing for RSV among patients who tested negative for COVID-19 but had “acute respiratory illness” symptoms. They also advised health care personnel, child care providers and staff of long-term care facilities to stay home from work if they had respiratory symptoms, even if they test negative for COVID, as they might have RSV.Like coronavirus, previous efforts to develop an RSV vaccine have met with failure as test subjects have a tendency to die or become seriously ill when exposed to the wild virus, thanks to paradoxical immune enhancement (PIE), also known as antibody dependent enhancement (ADE).

In New Zealand, health officials said there were few cases of RSV in 2020 during the pandemic and, while it’s normally a winter disease, it’s now making a comeback off-season in 2021. According to Stuff.co.nz,5 the outbreak “was more than twofold greater than the historical average from 2014 to 2019 for this time of year.”

Similar reports have been published in Japan where, in early July 2021, the National Institute of Infectious Diseases warned of RSV infections outside the normal peak period. According to the Japan Times:6

“… the number of RSV patients per medical institution was 3.87 in the week ending June 27 — the highest number of cases since 2019. In 2018, the year the counting system was changed, the infection count peaked in September at 2.46, and it reached 3.45 patients per medical institution a year later.”

August 3, 2021, U.S. health officials reported that RSV had started to taper off by midsummer, but a resurgence is now seen, with a “record-breaking 563 new RSV cases” reported in the week before August 3.7

FDA Fast-Tracks mRNA Shot Against RSV

That same day, August 3, 2021, the Food and Drug Administration granted fast-track designation to Moderna for an mRNA-based injection against this common cold virus.

[…]

Moderna’s press release correctly points out that there’s no approved vaccine available for RSV. What they don’t mention is why. The reason there’s no RSV vaccine on the market is the same reason why there has never been a coronavirus vaccine, and that is because none of them were able to pass trials.

As with coronavirus, previous efforts to develop an RSV vaccine have met with failure as test subjects have a pesky tendency to die or become seriously ill when exposed to the wild virus, thanks to paradoxical immune enhancement (PIE), also known as antibody dependent enhancement (ADE).9

RSV Shot Builds on COVID Jab

Moderna’s RSV shot uses the same lipid nanoparticle as its COVID-19 injection. The primary difference between the two shots is the coding of the mRNA. In the RSV shot, the mRNA encodes for a prefusion F glycoprotein.

Prefusion F protein is a protein that mediates the RSV virus’ entry into your cells and is known to elicit a neutralizing antibody response.10 Under normal circumstances, it’s hard to imagine an RSV vaccine built on a novel mRNA platform getting fast-tracked, but we’re no longer in normal times.

[…]

Are We Creating a Public Health Disaster?

The decision to fast-track yet another mRNA injection fails to take into consideration the possibility that we might already be creating an avalanche of ADE-related illness from the COVID shot. Adding another injection for a respiratory virus that has historically been associated with ADE could be extremely risky.

[…]

Via https://counterinformation.wordpress.com/2021/09/03/respiratory-syncytial-virus-rsv-fda-fast-tracks-rsv-mrna-vaccine-are-we-creating-a-public-health-disaster/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.